Arrhythmogenic cardiomyopathies (ACs): diagnosis, risk stratification and managementAlexandros Protonotarios, Perry M Elliott
21 February 2019
Peripartum cardiomyopathy: diagnosis and managementAlice M Jackson, Jonathan R Dalzell, Niki L Walker, Caroline J Coats, Pardeep S Jhund, Mark C Petrie
9 November 2017
Takotsubo cardiomyopathy: still much more to learnJelena R Ghadri, Frank Ruschitzka, Thomas F Lüscher, Christian Templin
7 April 2014
Linking left ventricular function and mural architecture: what does the clinician need to know?John B Partridge, Morten H Smerup, Steffen E Petersen, Peter F Niederer, Robert H Anderson
5 December 2013
How to monitor cardiac toxicity of chemotherapy: time is muscle!D Kerkhove, C Fontaine, S Droogmans, J De Greve, K Tanaka, Nico Van De Veire, Guy Van Camp
17 December 2013
Cardiac complications and manifestations of chemotherapy for cancerMuhammed Zeeshan Khawaja, Catherine Cafferkey, Ronak Rajani, Simon Redwood, David Cunningham
10 December 2013
Coronary microvascular dysfunction in primary cardiomyopathiesR Spoladore, A Fisicaro, A Faccini, P G Camici
31 July 2013
Diagnostic approach and differential diagnosis in patients with hypertrophied left ventriclesAli Yilmaz, Udo Sechtem
30 April 2013
Prevention of sudden cardiac death in hypertrophic cardiomyopathyConstantinos O'Mahony, Perry M Elliott
10 April 2013
Non-compaction cardiomyopathyAna G Almeida, Fausto J Pinto
16 March 2013